Multiplex Quantitative Real-Time PCR for Simultaneous Detection of Porcine Circovirus 2, Porcine Reproductive and Respiratory Syndrome Virus, and Swine Influenza A Virus in Field Samples
Introduction
Respiratory disease complexes in swine production systems frequently involve co-infections with multiple viral pathogens, complicating clinical diagnosis and disease management. Three of the most economically significant viral agents affecting swine herds globally are Porcine Circovirus 2 (PCV2), Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), and Swine Influenza A Virus (SIV). PCV2 is a small, non-enveloped, single-stranded DNA virus belonging to the family Circoviridae, and it is the primary etiological agent of porcine circovirus-associated disease (PCVAD), which includes postweaning multisystemic wasting syndrome (PMWS) [1, 2]. PRRSV, an enveloped, positive-sense single-stranded RNA virus in the family Arteriviridae, causes reproductive failure in sows and respiratory disease in growing pigs [3, 4]. SIV, an enveloped, negative-sense segmented RNA virus of the family Orthomyxoviridae, is a major cause of acute respiratory disease in pigs and can serve as a reservoir for novel influenza strains [3].
The clinical signs of these three infections overlap considerably, presenting as fever, cough, dyspnea, growth retardation, and increased mortality, particularly in nursery and finishing pigs [3, 1]. Co-infections are common and can exacerbate disease severity through synergistic immunological interactions [2]. For example, PRRSV-induced immunosuppression can potentiate PCV2 replication and lesion severity [1]. Traditional diagnostic methods, such as virus isolation and serology, are time-consuming, labor-intensive, and cannot reliably differentiate between concurrent active infections [4]. Therefore, a rapid, sensitive, and specific molecular diagnostic tool capable of simultaneous detection of these three pathogens is essential for effective surveillance, outbreak investigation, and implementation of control measures.
This article details the design, optimization, and validation of a triplex quantitative real-time PCR (qRT-PCR) assay targeting conserved genomic regions of PCV2, PRRSV, and SIV. The assay leverages the principles of multiplex fluorescence-based detection to provide a high-throughput, cost-effective solution for routine diagnostic laboratories.
Assay Design and Primer/Probe Selection
The foundation of any multiplex qRT-PCR assay is the careful selection of oligonucleotide primers and hydrolysis probes that exhibit high specificity for the target pathogens while minimizing cross-reactivity and primer-dimer formation. For the triplex assay described herein, target regions were selected based on their high degree of sequence conservation across known genotypes and strains of each virus.
Target Gene Selection
For PCV2, the conserved region within the open reading frame 2 (ORF2) gene, which encodes the immunogenic capsid protein, is the preferred target [1, 5]. This region is highly conserved among PCV2a, PCV2b, and PCV2d genotypes, ensuring broad strain coverage [2]. For PRRSV, the assay targets the conserved region of the ORF7 gene, which encodes the nucleocapsid (N) protein [3, 4]. This region is highly conserved across both PRRSV-1 (European) and PRRSV-2 (North American) genotypes, allowing for pan-PRRSV detection [6]. For SIV, the matrix (M) gene is selected due to its high conservation across all influenza A virus subtypes, including H1N1, H3N2, and H1N2 strains circulating in swine populations [3].
Oligonucleotide Design Criteria
Primers and probes were designed using bioinformatics software to meet the following criteria: melting temperature (Tm) between 58-60 degrees Celsius for primers and 68-70 degrees Celsius for probes, GC content between 40-60%, amplicon length between 70-150 base pairs, and minimal secondary structure formation. Each probe was labeled with a distinct fluorophore at the 5' end and a quencher (e.g., Black Hole Quencher) at the 3' end to enable spectral discrimination. A typical fluorophore assignment is FAM for PCV2, HEX (or VIC) for PRRSV, and Cy5 for SIV. This spectral separation is critical for accurate deconvolution of the multiplex signal.
Optimization of Multiplex Reaction Conditions
The transition from singleplex to multiplex qRT-PCR requires rigorous optimization of reaction components and thermal cycling parameters to maintain assay efficiency and sensitivity. Key variables include primer and probe concentrations, magnesium chloride concentration, annealing temperature, and the use of additives such as dimethyl sulfoxide (DMSO) or betaine to reduce secondary structure interference.
Primer and Probe Titration
Cross-reactivity and competitive inhibition between primer sets are common challenges in multiplex assays. To mitigate these effects, a checkerboard titration approach is employed. Initially, each primer pair is tested in singleplex at a standard concentration (e.g., 400 nM each). Subsequently, the concentration of each primer pair is systematically reduced (e.g., 200 nM, 100 nM) while the probe concentration is held constant (e.g., 200 nM) to identify the minimal concentration that yields a threshold cycle (Ct) value within 1-2 cycles of the singleplex reaction [4]. This process minimizes the risk of primer-dimer formation and conserves reagents.
Thermal Cycling Profile
A typical optimized thermal cycling protocol for a triplex qRT-PCR includes a reverse transcription step at 50 degrees Celsius for 30 minutes (required for RNA targets PRRSV and SIV), followed by an initial denaturation at 95 degrees Celsius for 10 minutes to activate the DNA polymerase. The amplification phase consists of 40-45 cycles of denaturation at 95 degrees Celsius for 15 seconds and combined annealing/extension at 60 degrees Celsius for 60 seconds. The annealing/extension temperature is optimized to be permissive for all three primer-probe sets simultaneously. A touchdown protocol, where the annealing temperature is decreased incrementally over the first few cycles, can further enhance specificity by reducing non-specific binding at lower temperatures.
Reaction Master Mix Composition
The final optimized reaction mixture typically contains a commercial one-step RT-qPCR master mix (which includes reverse transcriptase, DNA polymerase, dNTPs, and buffer), optimized concentrations of each primer and probe, a passive reference dye (e.g., ROX) for normalization, and nuclease-free water. The total reaction volume is typically 20-25 microliters, with a template volume of 2-5 microliters of extracted nucleic acid.
Analytical Sensitivity and Specificity
The analytical performance of the multiplex qRT-PCR assay is evaluated using standard metrics: analytical sensitivity (limit of detection, LoD), analytical specificity (inclusivity and exclusivity), amplification efficiency, and linear dynamic range.
Limit of Detection and Linearity
To determine the LoD, serial ten-fold dilutions of quantified synthetic RNA or DNA standards (e.g., plasmids containing the target sequences) or quantified viral stocks are tested in replicates. The LoD is defined as the lowest concentration at which 95% of replicates yield a positive signal. For a well-optimized triplex assay, the LoD for each target should be comparable to that of the corresponding singleplex assay, typically ranging from 10 to 100 copies per reaction [3, 4]. The standard curve generated from the serial dilutions should exhibit a correlation coefficient (R^2) greater than 0.98 and an amplification efficiency between 90% and 110% (slope of -3.1 to -3.6) [5].
Analytical Specificity
Analytical specificity is assessed by testing the assay against a panel of related and unrelated swine pathogens. Inclusivity is confirmed by testing multiple strains and genotypes of PCV2, PRRSV, and SIV. Exclusivity is confirmed by testing common co-infecting agents such as Porcine Circovirus 3 (PCV3), Porcine Circovirus 4 (PCV4), African Swine Fever Virus (ASFV), Classical Swine Fever Virus (CSFV), Pseudorabies Virus (PRV), Porcine Parvovirus (PPV), and Porcine Epidemic Diarrhea Virus (PEDV) [3, 1, 2]. No cross-reactivity should be observed with non-target pathogens. The use of locked nucleic acid (LNA) modified probes can further enhance specificity, particularly for discriminating between closely related genotypes such as PRRSV-1 and PRRSV-2 [6].
Comparison to Single-Target Assays
A critical validation step involves comparing the performance of the multiplex assay against established single-target qPCR or qRT-PCR assays. A panel of field samples (e.g., lung tissue, bronchoalveolar lavage fluid, nasal swabs, serum) is tested in parallel using both the multiplex and singleplex formats. The Ct values obtained from the multiplex assay should show a high degree of correlation with those from the singleplex assays, typically with a Pearson correlation coefficient (r) greater than 0.90 [3, 4]. Any systematic shift in Ct values (e.g., a consistent delay of 1-2 cycles) is acceptable as long as the diagnostic sensitivity and specificity remain unchanged.
Application in Routine Diagnostic Surveillance and Outbreak Investigations
The primary advantage of a multiplex qRT-PCR assay is its ability to provide a comprehensive virological profile from a single clinical sample, reducing turnaround time, labor, and reagent costs. This is particularly valuable in the context of porcine respiratory disease complex (PRDC), where multiple pathogens often act synergistically.
Workflow for Field Sample Testing
The following Mermaid diagram illustrates the typical workflow for processing field samples using the triplex assay.
flowchart TD
A[Field Sample Collection], > B[Nucleic Acid Extraction]
B, > C{Triplex qRT-PCR Setup}
C, > D[Thermal Cycling & Data Acquisition]
D, > E[Data Analysis & Interpretation]
E, > F{Pathogen Detection}
F, PCV2 Positive, > G[PCV2 Ct Value]
F, PRRSV Positive, > H[PRRSV Ct Value]
F, SIV Positive, > I[SIV Ct Value]
F, Negative, > J[No Pathogen Detected]
G, > K[Report Generation]
H, > K
I, > K
J, > K
K, > L[Clinical Decision & Herd Management]
Interpretation of Results
Results are interpreted based on the Ct values obtained for each fluorophore. A sample is considered positive for a given pathogen if the amplification curve crosses the threshold within 40 cycles. Samples with Ct values between 37 and 40 are considered weakly positive and should be retested or confirmed with a secondary assay. The relative viral load can be estimated by comparing Ct values to a standard curve, although absolute quantification requires the use of a standard curve run on the same plate. The ability to detect and semi-quantify all three viruses simultaneously allows veterinarians to identify the dominant pathogen in a co-infection and tailor therapeutic and management interventions accordingly.
Linking to Herd Health Management
The data generated by this assay can be integrated into broader herd health surveillance programs. For example, routine monitoring of nursery pigs for PCV2 and PRRSV can inform vaccination schedules and biosecurity protocols. Detection of SIV in a herd with acute respiratory signs can trigger immediate quarantine and subtype characterization to guide vaccine strain selection. The assay also supports epidemiological investigations by enabling rapid screening of large numbers of samples during an outbreak, facilitating the identification of transmission patterns and the implementation of targeted control measures.
Conclusion
The development and validation of a multiplex qRT-PCR assay for the simultaneous detection of PCV2, PRRSV, and SIV represents a significant advancement in swine diagnostic virology. By targeting conserved genomic regions and optimizing reaction conditions, the assay achieves analytical sensitivity and specificity comparable to single-target assays while offering substantial savings in time and resources. Its application in routine surveillance and outbreak investigations provides veterinarians and herd managers with critical, actionable data for the control of these economically devastating pathogens. Future refinements may include the incorporation of additional targets, such as PCV3 or PCV4, and the integration of the assay with automated nucleic acid extraction and liquid handling systems for high-throughput laboratory workflows.
References
[1] Li Z, Guan S, Zhao J, et al. Multiplex quantitative PCR assay for porcine circoviruses 2 and 3 and its application for measuring infection rates at different stages of pig production. Arch Virol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40522476/
[2] Mi Y, Huang D, Zhuo Y, et al. Development and preliminary application of a quadruplex real-time PCR assay for differential detection of porcine circovirus 1-4 in Chengdu, China. Front Vet Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38746930/
[3] Yin D, Xu S, Liu Y, et al. Development and Application of a Multiplex Real-Time TaqMan qPCR Assay for the Simultaneous Detection of African Swine Fever Virus, Classical Swine Fever Virus, Porcine Reproductive and Respiratory Syndrome Virus, Pseudorabies Virus, and Porcine Circovirus Type 2. Microorganisms. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40732082/
[4] Chen Y, Shi K, Liu H, et al. Development of a multiplex qRT-PCR assay for detection of African swine fever virus, classical swine fever virus and porcine reproductive and respiratory syndrome virus. J Vet Sci. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34854269/
[5] Zhao Y, Han HY, Fan L, et al. Development of a TB green II-based duplex real-time fluorescence quantitative PCR assay for the simultaneous detection of porcine circovirus 2 and 3. Mol Cell Probes. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/30980890/
[6] Gyurján I, Sipos-Kozma Z, Ásványi B, et al. Development and validation of an LNA-based multiplex RT-qPCR assay for differentiating Betaarterivirus europensis (PRRSV-1), Betaarterivirus americense (PRRSV-2), and the highly pathogenic L8 lineage of PRRSV-2. Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42235629/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.